Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy

Secondary Erythrocytosis Among Type 2 Diabetes Mellitus Patients With Hypogonadism Using Sodium‐Glucose Cotransporter 2 Inhibitors and Testosterone Replacement Therapy

ABSTRACT Hypogonadism is commonly linked to type 2 diabetes mellitus (T2DM), with testosterone replacement therapy (TRT) representing a key treatment option. Sodium glucose cotransporter‐2 inhibitors (SGLT‐2i) class is part of T2DM management. Both treatments can increase Hct, Hb and RBC levels with...

Full description

Saved in:
Bibliographic Details
Main Authors: Maharan Kabha, Hadar Dana, Sameer Kassem, Yoram Dekel, Hilla Cohen, Adnan Zaina
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
diabetes mellitus
erythrocytosis
hypogonadism
SGLT‐2 inhibitors
testosterone replacement therapy
Online Access:https://doi.org/10.1002/edm2.70064
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items